June 19, 2024

Short-read Sequencing Market Size To Cross USD 36 Bn By 2032

The global short-read sequencing market size accounted for US$ 6.3 Bn in 2022 and is projected to reach around USD 36 Bn by 2032, growing at a CAGR of 19.04% from 2023 to 2032.

Short-read Sequencing Market Size 2023 To 2032

Report Summary

The global short-read sequencing market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the short-read sequencing market across the globe.

A comprehensive estimate on the short-read sequencing market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of short-read sequencing during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2887

Short-read Sequencing Market Report Scope 

Report CoverageDetails
Market Size in 2023USD 7.5 Billion
Market Size by 2032USD 36 Billion
Growth Rate from 2023 to 2032CAGR of 19.4%
Largest MarketNorth America
Fastest Growing MarketAsia Pacific
Base Year2022
Forecast Period2023 to 2032
Segments CoveredBy Technology, By Workflow, By Product, By Application, and By End User
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Key Highlights: 

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized short-read sequencing market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read:  Diabetes Drug Market Size To Cross USD 118 Bn By 2032

Short-read Sequencing Market Players

The report includes the profiles of key short-read sequencing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • BGI
  • Agilent Technologies
  • Thermo Fisher Scientific, Inc.
  • ProPhase Labs, Inc. (Nebula Genomics)
  • Illumina, Inc.
  • Psomagen
  • QIAGEN
  • Azenta US, Inc. (GENEWIZ)
  • PerkinElmer, Inc.
  • Pacific Biosciences of California, Inc.
  • Cytiva
  • Fasteris SA
  • Genewiz
  • GenScript

Market Segmentation

By Technology

  • Next-Generation Sequencing
  • Sanger Sequencing

By Workflow

  • Pre-Sequencing
  • Sequencing
  • Data Analysis

By Product

  • Instruments
  • Consumables
  • Services

By Application

  • Clinical Investigation
  • Oncology
  • Reproductive Health
  • Consumer Genomics
  • Agri genomics and Forensics
  • HLA Typing/ Immune System Monitoring

By End User

  • Academic Research
  • Hospital and Clinics
  • Clinical Research
  • Pharmaceutical and Biotechnology Companies

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Short-read Sequencing Market 

5.1. COVID-19 Landscape: Short-read Sequencing Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Short-read Sequencing Market, By Technology

8.1. Short-read Sequencing Market, by Technology, 2023-2032

8.1.1. Next-Generation Sequencing

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Sanger Sequencing

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Short-read Sequencing Market, By Workflow

9.1. Short-read Sequencing Market, by Workflow, 2023-2032

9.1.1. Pre-Sequencing

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Sequencing

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Data Analysis

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Short-read Sequencing Market, By Product 

10.1. Short-read Sequencing Market, by Product, 2023-2032

10.1.1. Instruments

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Consumables

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Services

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Short-read Sequencing Market, By Application

11.1. Short-read Sequencing Market, by Application, 2023-2032

11.1.1. Clinical Investigation

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Oncology

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Reproductive Health

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Consumer Genomics

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Agri genomics and Forensics

11.1.5.1. Market Revenue and Forecast (2020-2032)

11.1.6. HLA Typing/ Immune System Monitoring

11.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Short-read Sequencing Market, By End User

12.1. Short-read Sequencing Market, by End User, 2023-2032

12.1.1. Academic Research

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Hospital and Clinics

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Clinical Research

12.1.3.1. Market Revenue and Forecast (2020-2032)

12.1.4. Pharmaceutical and Biotechnology Companies

12.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global Short-read Sequencing Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Technology (2020-2032)

13.1.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.1.3. Market Revenue and Forecast, by Product (2020-2032)

13.1.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.5. Market Revenue and Forecast, by End User (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.1.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.6.5. Market Revenue and Forecast, by End User (2020-2032)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Technology (2020-2032)

13.1.7.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.1.7.3. Market Revenue and Forecast, by Product (2020-2032)

13.1.7.4. Market Revenue and Forecast, by Application (2020-2032)

13.1.7.5. Market Revenue and Forecast, by End User (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.5. Market Revenue and Forecast, by End User (2020-2032)

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.7. Market Revenue and Forecast, by Application (2020-2032)

13.2.8. Market Revenue and Forecast, by End User (2020-2032)

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.10. Market Revenue and Forecast, by Application (2020-2032)

13.2.11. Market Revenue and Forecast, by End User (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.12.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.13. Market Revenue and Forecast, by End User (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Technology (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Product (2020-2032)

13.2.14.4. Market Revenue and Forecast, by Application (2020-2032)

13.2.15. Market Revenue and Forecast, by End User (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.5. Market Revenue and Forecast, by End User (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.7. Market Revenue and Forecast, by End User (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.9. Market Revenue and Forecast, by End User (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.10.5. Market Revenue and Forecast, by End User (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Technology (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Product (2020-2032)

13.3.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.3.11.5. Market Revenue and Forecast, by End User (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.5. Market Revenue and Forecast, by End User (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.7. Market Revenue and Forecast, by End User (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.9. Market Revenue and Forecast, by End User (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.10.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.10.5. Market Revenue and Forecast, by End User (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Technology (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Product (2020-2032)

13.4.11.4. Market Revenue and Forecast, by Application (2020-2032)

13.4.11.5. Market Revenue and Forecast, by End User (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Technology (2020-2032)

13.5.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.5.3. Market Revenue and Forecast, by Product (2020-2032)

13.5.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.5. Market Revenue and Forecast, by End User (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Technology (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Product (2020-2032)

13.5.6.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.7. Market Revenue and Forecast, by End User (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Technology (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Workflow (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Product (2020-2032)

13.5.8.4. Market Revenue and Forecast, by Application (2020-2032)

13.5.8.5. Market Revenue and Forecast, by End User (2020-2032)

Chapter 14. Company Profiles

14.1. BGI

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Agilent Technologies

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Thermo Fisher Scientific, Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. ProPhase Labs, Inc. (Nebula Genomics)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Illumina, Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Psomagen

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. QIAGEN

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Azenta US, Inc. (GENEWIZ)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. PerkinElmer, Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Pacific Biosciences of California, Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com